Overview

Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and imaging ability of 111In-DAC when used with planar and SPECT imaging for the detection of breast cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Copharos